Researchers at The Hospital for Sick Children
(SickKids) have determined that women being treated for multiple sclerosis
(MS) with beta interferon therapy have increased risks of miscarriage or low
infant-birth weight. This research was reported in the September issue of the
journal Neurology.
Beta interferon therapy is the most commonly used therapy for treating
relapsing-remitting MS. Based on a protein found naturally in the body that
helps to regulate the immune system, it is known to help decrease the
formation of lesions, reduce the frequency of relapses and help affect the
course of the disease.{CLICK FOR MORE}